Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2024-10-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
关于聘任公司副总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new company vice general manager, including details about the individual's qualifications and shareholdings. It is a formal disclosure by the company's board about a management change. There is no financial data, no report or presentation, and no mention of voting results or legal proceedings. The content fits the category of announcements about changes in the company's board or senior management.
2024-10-28 Chinese
第九届董事会第三十二次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of a board meeting resolution by Northeast Pharmaceutical Group Co., Ltd. It details the convening of the 32nd meeting of the 9th Board of Directors, the attendance, the legality of the meeting, and the approval of a proposal to appoint a deputy general manager. It references another announcement for more details on the appointment. The document is short (619 characters) and focuses on board/management changes rather than financial results or reports. Therefore, it fits the category of Board/Management Information (MANG).
2024-10-28 Chinese
关于股东部分股份质押展期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the extension of a pledge on shares held by a major shareholder of the company. It details the number of shares pledged, the pledge period, and assurances about the financial status and control implications. There are no financial statements, earnings data, or management discussions. The content is focused on shareholder share pledge extension, which relates to capital or financing activities. Therefore, the document fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Hence, the classification is CAP with high confidence.
2024-10-24 Chinese
2024年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "东北制药集团股份有限公司2024 年第三季度报告" which translates to "Northeast Pharmaceutical Group Co., Ltd. 2024 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period ending September 30, 2024. It also mentions that the report is unaudited, which is typical for interim or quarterly reports. The length of the document (over 12,000 characters) and the presence of substantive financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2024
2024-10-23 Chinese
关于副总经理辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's Vice General Manager, including details about the resignation, stock holdings, and compliance with relevant regulations. It does not contain financial data, audit information, or report content. It is clearly about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management change, not a report or announcement of a report publication.
2024-10-15 Chinese
2024年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2024 second extraordinary shareholders' meeting of Dongbei Pharmaceutical Group Co., Ltd. It details the meeting date, attendance, voting results on proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official voting results and resolutions passed at the shareholders' meeting, including details on voting percentages and legal compliance. There is no financial data, earnings information, or management discussion. The document is not a report itself but an official announcement of the voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2318 characters), consistent with an announcement rather than a full report.
2024-09-12 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.